Breckenridge gets FDA green light for generic Onfi

Press enter to search
Close search
Open Menu

Breckenridge gets FDA green light for generic Onfi

By Sandra Levy - 10/24/2018
Breckenridge Pharmaceutical has received the Food and Drug Administration's blessing for clobazam tablets.

The product, which is the generic version of Lundbeck’s Onfi tablets, will be available in 10-mg and 20-mg tablets.

Clobazam tablets are a benzodiazepine indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients age 2 years old and older.

Onfi had a market value of $594 million for the 12 months ended Aug. 31, 2018, according to IQVIA data.

RELATED TOPICS